Clinical Trial Update: The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of SerpinPC in participants with severe Hemophilia A or moderately severe to severe Hemophilia B has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• SerpinPC

Snippet

Sponsor: ApcinteX Ltd | Conditions: Hemophilia a, Hemophilia B | Phase 2 | Status: TERMINATED